Inchin South, Scotland, May 27, 2021 /PRNewswire/ – Thermo Fisher Scientific, a global leader in scientific services, today announced that its TaqPath COVID-19 CE-IVD RT PCR kit has been independent It is verified that international travelers arriving in the UK that meet the performance characteristics of the day need to undergo COVID-19 quarantine protocol testing on the 2nd and 8th days.
Britain has established quarantine regulations for incoming passengers, which vary according to the country of departure, but the law requires most people to be quarantined for ten days after arrival. On the 2nd and 8th days of quarantine, these travelers must undergo a PCR test to monitor for active SARS-CoV-2 infection. Thermo Fisher’s TaqPath kit is now allowed to be used by laboratories and clinics in this monitoring.
Claire Wallace, vice president of business for Thermo Life Sciences Europe, Middle East and Africa, said: “As countries begin to reopen, such as the UK’s quarantine and surveillance program will help curb SARS-CoV-2 and its variants. Transmission is very important. Fisher Scientific. “Since the beginning of the pandemic, Thermo Fisher’s strong and high-precision COVID-19 PCR testing supply chain has been the basis for SARS-CoV-2 symptom testing in the United Kingdom. Independent verification of additional uses will help increase test availability as the international travel season begins. ”
The TaqPathCOVID-19 CE-IVD RT PCR kit is a fast and highly sensitive multiple diagnostic solution, which contains the assays and controls required for real-time PCR detection of SARS-CoV-2 virus RNA. In an independent validation study, the clinical sensitivity of the kit was 100%, the confidence interval was 95% [97.9-100.0%], the clinical specificity was 100%, and the confidence interval was 95% [98.6-100.0%]. The detection limit was determined to be 250 copies/ml.
The TaqPathCOVID-19 CE-IVD RT PCR Kit received preliminary CE-IVD approval in March 2020 and is compatible with the most widely used real-time PCR instruments. For more information about the platform, please visit: https://www.thermofisher.com/covid19ceivd
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is a global leader in scientific services with annual revenues of more than 30 billion U.S. dollars. Our mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life science research, solving complex analytical challenges, improving patient diagnosis and treatment, or improving laboratory productivity, we will support them. Our global team of more than 80,000 colleagues provides an unparalleled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands (including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon). For more information, please visit www.thermofisher.com.
Media Contact Mauricio Minotta Director of Public Relations Tel: +1 760-929-2456 Email: mauricio.minotta@thermofisher.com
Post time: Jun-18-2021
